See What HealthDay Can Do For You
Contact Us

Transporter Gene Linked to Attention-Deficit Disorder

Polymorphism near norepinephrine gene correlates with lower expression

TUESDAY, Dec. 5 (HealthDay News) -- A variation of the norepinephrine transporter gene is strongly associated with attention-deficit/hyperactivity disorder (ADHD), according to study findings published online Dec. 4 in the Proceedings of the National Academy of Sciences Early Edition.

Kwang-Soo Kim, Ph.D., of Harvard Medical School and McLean Hospital in Belmont, Mass., and colleagues studied a previously uncharacterized A/T polymorphism known to occur upstream of the norepinephrine transporter gene (SLC6A2) start site. They genotyped 94 ADHD patients and 60 healthy controls.

The investigators found that the T allele was much weaker at driving expression of a reporter gene because it becomes a binding site for transcriptional repressor proteins found in neurons. These repressors, called Slug and Scratch, were shown to bind specifically to the T allele. The A/T polymorphism in the SLC6A2 gene was twice as common in patients than controls.

"We observed a significant association between the [T allele] and ADHD, suggesting that anomalous transcription factor-based repression of SLC6A2 may increase risk for the development of ADHD and other neuropsychiatric diseases," the authors conclude.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.